Page last updated: 2024-08-17

1,2-dipalmitoylphosphatidylcholine and Lung Diseases, Interstitial

1,2-dipalmitoylphosphatidylcholine has been researched along with Lung Diseases, Interstitial in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aslanidis, C; Brasch, F; Frixel, S; Griese, M; Hegermann, J; Höppner, S; Kinting, S; Kröner, C; Lasch, P; Liebisch, G; Reu, S; Schindlbeck, U; Wittmann, T; Zarbock, R1

Other Studies

1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Lung Diseases, Interstitial

ArticleYear
Tools to explore ABCA3 mutations causing interstitial lung disease.
    Pediatric pulmonology, 2016, Volume: 51, Issue:12

    Topics: 1,2-Dipalmitoylphosphatidylcholine; A549 Cells; ATP-Binding Cassette Transporters; Bronchoalveolar Lavage Fluid; Cell Survival; Fatal Outcome; Fluorescent Antibody Technique; Glycosylation; Humans; Immunoblotting; Immunohistochemistry; Infant; Lung; Lung Diseases, Interstitial; Microscopy, Confocal; Microscopy, Electron; Mutation; Pulmonary Surfactant-Associated Protein C; Real-Time Polymerase Chain Reaction

2016